Related Experiment Video
Updated: Jul 14, 2026

Ultrasonographic Evaluation of Breast Cancer-related Lymphedema
Published on: January 12, 2017
Effects of aerobic training prior to and during chemotherapy in a breast cancer patient: a case study
Daniela Terson de Paleville1, Robert V Topp, Ann M Swank
1Exercise Physiology Laboratory, University of Louisville, Louisville, Kentucky 40292, USA.
Abstract:
Treatment for breast cancer patients includes surgical removal of the tumor followed by chemotherapy. Chemotherapy frequently results in difficult to manage symptoms that threaten compliance with the therapy. Symptoms include fatigue, declines in functional ability, muscle wasting, and a decreased quality of life. Preparing the body to tolerate a stressful event such as chemotherapy has been termed "prehabilitation". This case study determined the efficacy of introducing aerobic training 1 week prior to and continuing through 8 weeks of chemotherapy on fatigue and functional ability in a 42-year-old newly diagnosed breast cancer patient. The patient participated in a supervised and home-based walking program. Fatigue during daily activities and functional ability (12-minute walk, ascending and descending stairs, sit to stand, getting to and rising from the floor, 30-second bicep curl) were measured before and after exercise training. Results indicate that 5 of 7 functional measures demonstrated improvement, ranging from 23.4- 54.5%. In addition, fatigue while performing activities of daily living, as well as following the performance of the functional tasks, was reduced. The findings of this case study indicate that fatigue can be decreased and functional ability can be improved as a result of aerobic training initiated 1 week before and continued throughout chemotherapy. This case study presents a novel approach to introducing exercise prior to and continued during 8 weeks of chemotherapy in a way that may reduce the cumulative effects of this stressor.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Survival Analysis